Skip to main content
Erschienen in: Diagnostic Pathology 1/2013

Open Access 01.12.2013 | Case Report

Lymphoepithelioma-like carcinoma of the stomach: a case report and review of the literature

verfasst von: Zeid Bittar, Falko Fend, Leticia Quintanilla-Martinez

Erschienen in: Diagnostic Pathology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

A lymphoepithelioma-like carcinoma (LLC), characterized by a carcinoma with stromal heavy lymphocyte infiltration, is one of the histological patterns observed in patients with Epstein-Barr virus (EBV)-associated gastric carcinoma. Although this entity is hard to be recognized in the biopsy specimens, pathologists and clinicians should acknowledge this subset of gastric cancer because it generally has a better prognosis than other forms of EBV-associated gastric carcinomas and conventional gastric carcinomas. This might be due to the fact that the patient's inflammatory response may prevent the spread of tumor through the gastric wall and to the lymph nodes or remote organs.
We report a case of EBV-positive, microsatellite stable LLC as a rare morphologic variant of gastric carcinoma.

Virtual slides

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Watanabe H, Enjoji M, Imai T: Gastric carcinoma with lymphoid stroma: its morphologic characteristic and prognostic correlations. Cancer. 1976, 38: 232-243. 10.1002/1097-0142(197607)38:1<232::AID-CNCR2820380135>3.0.CO;2-4.CrossRefPubMed Watanabe H, Enjoji M, Imai T: Gastric carcinoma with lymphoid stroma: its morphologic characteristic and prognostic correlations. Cancer. 1976, 38: 232-243. 10.1002/1097-0142(197607)38:1<232::AID-CNCR2820380135>3.0.CO;2-4.CrossRefPubMed
2.
Zurück zum Zitat Torlakovic G, Snover DC, Torlakovic E: Simultaneous EBV-positive lymphoepithelioma-like carcinoma and EBV-negative intestinal type adenocarcinoma in a patient with Helicobacter pylori–associated chronic gastritis. Am J Clin Pathol. 2004, 121: 237-243. 10.1309/MD3BD8Y1Q5X983LG.CrossRefPubMed Torlakovic G, Snover DC, Torlakovic E: Simultaneous EBV-positive lymphoepithelioma-like carcinoma and EBV-negative intestinal type adenocarcinoma in a patient with Helicobacter pylori–associated chronic gastritis. Am J Clin Pathol. 2004, 121: 237-243. 10.1309/MD3BD8Y1Q5X983LG.CrossRefPubMed
3.
Zurück zum Zitat Horiuchi K, Mishima K, Ohsawa M, et al.: Carcinoma of stomach and breast with lymphoid stroma: localization of Epstein Barr virus. J Clin Pathol. 1994, 47: 538-540. 10.1136/jcp.47.6.538.PubMedCentralCrossRefPubMed Horiuchi K, Mishima K, Ohsawa M, et al.: Carcinoma of stomach and breast with lymphoid stroma: localization of Epstein Barr virus. J Clin Pathol. 1994, 47: 538-540. 10.1136/jcp.47.6.538.PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Corvalan A, Koriyama C, Akiba S, et al.: Epstein-Barr virus in gastric carcinoma is associated with localization in the cardia and with a diffuse histology: a study in one area of Chile. Int J Canc. 2001, 94: 527-530. 10.1002/ijc.1510.CrossRef Corvalan A, Koriyama C, Akiba S, et al.: Epstein-Barr virus in gastric carcinoma is associated with localization in the cardia and with a diffuse histology: a study in one area of Chile. Int J Canc. 2001, 94: 527-530. 10.1002/ijc.1510.CrossRef
5.
Zurück zum Zitat Grogg KL, Lohse CM, Pankratz VS, et al.: Lymphocyte-rich gastric cancer: association with Epstein-Barr virus, microsatellite instability, histology and survival. Mod Pathol. 2003, 16: 641-651. 10.1097/01.MP.0000076980.73826.C0.CrossRefPubMed Grogg KL, Lohse CM, Pankratz VS, et al.: Lymphocyte-rich gastric cancer: association with Epstein-Barr virus, microsatellite instability, histology and survival. Mod Pathol. 2003, 16: 641-651. 10.1097/01.MP.0000076980.73826.C0.CrossRefPubMed
6.
Zurück zum Zitat Fukayama M, Ushiku T: Epstein-Barr virus-associated gastric carcinoma. Pathol Res Pract. 2011, 207: 529-537. 10.1016/j.prp.2011.07.004.CrossRefPubMed Fukayama M, Ushiku T: Epstein-Barr virus-associated gastric carcinoma. Pathol Res Pract. 2011, 207: 529-537. 10.1016/j.prp.2011.07.004.CrossRefPubMed
8.
Zurück zum Zitat Hiroshi S, Akinori N, Masayuki K, et al.: Oesophageal and gastric cancer. J Gastroenterol Hepatol. 1999, 14: 534-539. Hiroshi S, Akinori N, Masayuki K, et al.: Oesophageal and gastric cancer. J Gastroenterol Hepatol. 1999, 14: 534-539.
9.
Zurück zum Zitat Iwashita A, Ueyama T, Yamada Y, et al.: Clinicopathological study on medullary carcinoma with lymphoid stroma of the stomach. I to Cho (Stomach and Intestine). 1991, 10: 1159-1166. [Japanese with English abstract] Iwashita A, Ueyama T, Yamada Y, et al.: Clinicopathological study on medullary carcinoma with lymphoid stroma of the stomach. I to Cho (Stomach and Intestine). 1991, 10: 1159-1166. [Japanese with English abstract]
10.
Zurück zum Zitat Minamoto T, Mai M, Watanabe K, et al.: Medullary carcinoma with lymphocytic infiltration of the stomach. Clinicopathologic study of the subpopulations of infiltrating lymphocytes in the tumor. Cancer. 1990, 66: 945-952. 10.1002/1097-0142(19900901)66:5<945::AID-CNCR2820660523>3.0.CO;2-X.CrossRefPubMed Minamoto T, Mai M, Watanabe K, et al.: Medullary carcinoma with lymphocytic infiltration of the stomach. Clinicopathologic study of the subpopulations of infiltrating lymphocytes in the tumor. Cancer. 1990, 66: 945-952. 10.1002/1097-0142(19900901)66:5<945::AID-CNCR2820660523>3.0.CO;2-X.CrossRefPubMed
11.
Zurück zum Zitat Shibata D, Tokunaga M, Uemura Y, et al.: Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration, lymphoepithelioma-like carcinoma. Am J Pathol. 1991, 139: 469-474.PubMedCentralPubMed Shibata D, Tokunaga M, Uemura Y, et al.: Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration, lymphoepithelioma-like carcinoma. Am J Pathol. 1991, 139: 469-474.PubMedCentralPubMed
12.
Zurück zum Zitat Beek JV, Hausen AZ, Kranenbarg EK, et al.: EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol. 2004, 22: 664-670. 10.1200/JCO.2004.08.061.CrossRefPubMed Beek JV, Hausen AZ, Kranenbarg EK, et al.: EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol. 2004, 22: 664-670. 10.1200/JCO.2004.08.061.CrossRefPubMed
13.
Zurück zum Zitat Chang MS, Kim WH, Kim CW, et al.: Epstein-Barr virus in gastric carcinomas with lymphoid stroma. Histopathology. 2000, 37: 309-315. 10.1046/j.1365-2559.2000.01014.x.CrossRefPubMed Chang MS, Kim WH, Kim CW, et al.: Epstein-Barr virus in gastric carcinomas with lymphoid stroma. Histopathology. 2000, 37: 309-315. 10.1046/j.1365-2559.2000.01014.x.CrossRefPubMed
14.
Zurück zum Zitat Kang GH, Lee S, Kim WH, et al.: Epstein-Barr virus–positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol. 2002, 160: 787-794. 10.1016/S0002-9440(10)64901-2.PubMedCentralCrossRefPubMed Kang GH, Lee S, Kim WH, et al.: Epstein-Barr virus–positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol. 2002, 160: 787-794. 10.1016/S0002-9440(10)64901-2.PubMedCentralCrossRefPubMed
15.
16.
Zurück zum Zitat Uemura Y, Tokunaga M, Arikawa J, et al.: A unique morphology of Epstein-Barr virus related early gastric carcinoma. Canc Epidemiol Biomarkers Prev. 1994, 3: 607-611. Uemura Y, Tokunaga M, Arikawa J, et al.: A unique morphology of Epstein-Barr virus related early gastric carcinoma. Canc Epidemiol Biomarkers Prev. 1994, 3: 607-611.
17.
Zurück zum Zitat Vo QN, Geradts J, Gulley ML, et al.: Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation. J Clin Pathol. 2002, 55: 669-675. 10.1136/jcp.55.9.669.PubMedCentralCrossRefPubMed Vo QN, Geradts J, Gulley ML, et al.: Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation. J Clin Pathol. 2002, 55: 669-675. 10.1136/jcp.55.9.669.PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Osato T, Imai S: Epstein-Barr virus and gastric carcinoma. Semin Canc Biol. 1996, 7: 175-182. 10.1006/scbi.1996.0024.CrossRef Osato T, Imai S: Epstein-Barr virus and gastric carcinoma. Semin Canc Biol. 1996, 7: 175-182. 10.1006/scbi.1996.0024.CrossRef
19.
Zurück zum Zitat Kaneda A, Kaminishi M, Yanagihara K, et al.: Identification of silencing of nine genes in human gastric cancers. Canc Res. 2002, 62: 6645-6650. Kaneda A, Kaminishi M, Yanagihara K, et al.: Identification of silencing of nine genes in human gastric cancers. Canc Res. 2002, 62: 6645-6650.
20.
Zurück zum Zitat Hino R, Uozaki H, Murakami N, et al.: Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Canc Res. 2009, 69: 2766-2774. 10.1158/0008-5472.CAN-08-3070.CrossRef Hino R, Uozaki H, Murakami N, et al.: Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Canc Res. 2009, 69: 2766-2774. 10.1158/0008-5472.CAN-08-3070.CrossRef
21.
Zurück zum Zitat Chang MS, Uozaki H, Chong JM, et al.: CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Clin Canc Res. 2006, 12: 2995-3002. 10.1158/1078-0432.CCR-05-1601.CrossRef Chang MS, Uozaki H, Chong JM, et al.: CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Clin Canc Res. 2006, 12: 2995-3002. 10.1158/1078-0432.CCR-05-1601.CrossRef
22.
Zurück zum Zitat Lee JH, Park SJ, Abraham SC, et al.: Frequent CpG island methylation in precursor lesion and early lesions and early gastric adenocarcinomas. Oncogene. 2004, 23: 4646-4654. 10.1038/sj.onc.1207588.CrossRefPubMed Lee JH, Park SJ, Abraham SC, et al.: Frequent CpG island methylation in precursor lesion and early lesions and early gastric adenocarcinomas. Oncogene. 2004, 23: 4646-4654. 10.1038/sj.onc.1207588.CrossRefPubMed
23.
Zurück zum Zitat Chang MS, Lee HS, Kin CW, et al.: Clinocopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea. Pathol Res Pract. 2001, 197: 395-400. 10.1078/0344-0338-00052.CrossRefPubMed Chang MS, Lee HS, Kin CW, et al.: Clinocopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea. Pathol Res Pract. 2001, 197: 395-400. 10.1078/0344-0338-00052.CrossRefPubMed
24.
Zurück zum Zitat Chong JM, Fukayama M, Hayashi Y, et al.: Microsatellite instability in the progression of gastric carcinoma. Canc Res. 1994, 54: 4595-4597. Chong JM, Fukayama M, Hayashi Y, et al.: Microsatellite instability in the progression of gastric carcinoma. Canc Res. 1994, 54: 4595-4597.
25.
Zurück zum Zitat Leung SY, Yuen ST, Chung LP, et al.: Microsatellite instability, Epstein Barr virus, mutation of type II transforming growth factor receptor and BAX in gastric carcinomas in Hong Kong Chinese. Br J Canc. 1999, 79: 582-588. 10.1038/sj.bjc.6690092.CrossRef Leung SY, Yuen ST, Chung LP, et al.: Microsatellite instability, Epstein Barr virus, mutation of type II transforming growth factor receptor and BAX in gastric carcinomas in Hong Kong Chinese. Br J Canc. 1999, 79: 582-588. 10.1038/sj.bjc.6690092.CrossRef
26.
Zurück zum Zitat Ojima H, Fukuda T, Nakajima T, et al.: Infrequent overexpression of p53 protein in Epstein-Barr virus–associated gastric carcinomas. Jpn J Canc Res. 1997, 88: 262-266. 10.1111/j.1349-7006.1997.tb00376.x.CrossRef Ojima H, Fukuda T, Nakajima T, et al.: Infrequent overexpression of p53 protein in Epstein-Barr virus–associated gastric carcinomas. Jpn J Canc Res. 1997, 88: 262-266. 10.1111/j.1349-7006.1997.tb00376.x.CrossRef
27.
Zurück zum Zitat Leung SY, Chau KY, Yuen ST, et al.: p53 overexpression is different in Epstein-Barr virus–associated and Epstein-Barr virus–negative carcinoma. Histopathology. 1998, 33: 311-317.PubMed Leung SY, Chau KY, Yuen ST, et al.: p53 overexpression is different in Epstein-Barr virus–associated and Epstein-Barr virus–negative carcinoma. Histopathology. 1998, 33: 311-317.PubMed
28.
Zurück zum Zitat Fukayama M, Chong JM, Kaizaki Y: Epstein-Barr virus and gastric carcinoma. Gastric Canc. 1998, 1: 104-114. 10.1007/s101200050003.CrossRef Fukayama M, Chong JM, Kaizaki Y: Epstein-Barr virus and gastric carcinoma. Gastric Canc. 1998, 1: 104-114. 10.1007/s101200050003.CrossRef
29.
Zurück zum Zitat Kijima Y, Ishigami S, Hokita S, et al.: The comparison of the prognosis between Epstein-Barr virus (EBV)–positive gastric carcinoma and EBV-negative ones. Canc Lett. 2003, 200: 33-40. 10.1016/S0304-3835(03)00410-5.CrossRef Kijima Y, Ishigami S, Hokita S, et al.: The comparison of the prognosis between Epstein-Barr virus (EBV)–positive gastric carcinoma and EBV-negative ones. Canc Lett. 2003, 200: 33-40. 10.1016/S0304-3835(03)00410-5.CrossRef
30.
Zurück zum Zitat Beghelli S, de Manzoni G, Barbi S, et al.: Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers. Surgery. 2006, 139: 347-356. 10.1016/j.surg.2005.08.021.CrossRefPubMed Beghelli S, de Manzoni G, Barbi S, et al.: Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers. Surgery. 2006, 139: 347-356. 10.1016/j.surg.2005.08.021.CrossRefPubMed
Metadaten
Titel
Lymphoepithelioma-like carcinoma of the stomach: a case report and review of the literature
verfasst von
Zeid Bittar
Falko Fend
Leticia Quintanilla-Martinez
Publikationsdatum
01.12.2013
Verlag
BioMed Central
Erschienen in
Diagnostic Pathology / Ausgabe 1/2013
Elektronische ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-8-184

Weitere Artikel der Ausgabe 1/2013

Diagnostic Pathology 1/2013 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …